277 F. Supp. 3d 291
D. Conn.2017Background
- Cigna acquired HealthSpring in 2012, making Medicare (Parts C/D) business a major revenue source; CMS regulates these plans and can impose sanctions that limit enrollment/marketing.
- Between 2013–2016, Cigna received multiple CMS notices (allegedly dozens/75 total by end of class period) for various compliance deficiencies; CMS audited Cigna in Oct. 2015 and in Jan. 2016 imposed intermediate sanctions suspending enrollment and marketing.
- Proposed Lead Plaintiff Singh (class representative) filed a securities-fraud suit under §10(b)/Rule 10b-5 and §20(a) alleging Cigna and officers made materially false/misleading statements in 2013–2014 Form 10-Ks and Code of Ethics by failing to disclose ongoing, substantial noncompliance with CMS rules, and that defendants traded stock during the Class Period.
- Defendants moved to dismiss for failure to plead falsity, scienter, and loss causation with the particularity required by Rule 9(b) and the PSLRA; the court considered the SAC, SEC filings, CMS reports/letters, and other public documents.
- The court concluded the 2013 and 2014 10-Ks and quoted ethics statements were either non-actionable puffery or not shown to be materially misleading when made, found scienter inadequately pled (confidential witness allegations and insider sales insufficient), but found loss causation would have been adequately pled if a primary violation were established.
- The court dismissed all claims with prejudice and denied further leave to amend as futile after accounting for prior opportunities to replead and discovery allowed by the court.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Material misstatement/omission (10-Ks & Code of Ethics) | Singh: 10-Ks and public statements misled investors by concealing systemic, ongoing CMS non-compliance. | Cigna: statements were generic risk disclosures or puffery; no duty to disclose routine/curable CMS notices; many notices post-dated the statements. | Court: Statements were puffery or not materially misleading at time made; omissions not shown to be ‘‘ongoing and substantial’’ when 10-Ks issued — no actionable misstatement. |
| Scienter (knowledge/recklessness) | Singh: defendants had access to compliance notices, insider sales, and CW reports showing integration failures, supporting a strong inference of scienter. | Cigna: allegations are conclusory; insider sales executed under 10b5‑1 plans or otherwise not suspicious; CWs don't tie specific knowledge to defendants. | Court: Scienter inadequately pled. CWs and sales do not yield a cogent, compelling inference of intent or conscious recklessness. |
| Loss causation | Singh: stock drops after Jan 22, 2016 8‑K (sanctions) and July 29, 2016 10‑Q remedial-cost disclosure show corrective disclosures and causal link. | Cigna: challenges causal connection to alleged misstatements. | Court: If a primary misrepresentation had been established, loss causation would be adequately pled (market reacted to sanctions disclosure). But because no primary violation established, §10(b) claim fails. |
| Control-person liability (§20(a)) | Singh: Cordani, McCarthy, Appel controlled Cigna and are liable as control persons. | Cigna: no primary violation, so no secondary/control liability. | Court: Dismissed §20(a) because no primary §10(b) violation was established. |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (pleading must state a plausible claim)
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (two‑pronged plausibility review for complaints)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (PSLRA scienter standard: strong inference must be as compelling as any opposing inference)
- Stratte‑McClure v. Morgan Stanley, 776 F.3d 94 (2d Cir. 2015) (duty to disclose arises where necessary to make prior statements not misleading)
- In re JinkoSolar Holding Co. Sec. Litig., 761 F.3d 245 (2d Cir. 2014) (failure to disclose ongoing, substantial regulatory violations can be material despite general risk warnings)
- Kleinman v. Elan Corp., 706 F.3d 145 (2d Cir. 2013) (materiality and pleading standards in securities cases)
- ECA, Local 134 IBEW Joint Pension Trust of Chicago v. JP Morgan Chase Co., 553 F.3d 187 (2d Cir. 2009) (materiality: effect on the total mix of information)
- Rombach v. Chang, 355 F.3d 164 (2d Cir. 2004) (puffery and inadequacy of ‘‘handful of incidents’’ to show materially misleading statements)
- Lentell v. Merrill Lynch & Co., Inc., 396 F.3d 161 (2d Cir. 2005) (loss causation standard in securities fraud)
- Novak v. Kasaks, 216 F.3d 300 (2d Cir. 2000) (requirements for confidential witness allegations to show defendants’ knowledge)